Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32 results about "Non targeted metabolomics" patented technology

GC-MS-based plant non-targeted metabolomics sample pretreatment method

The invention discloses a GC-MS-based plant non-targeted metabolomics sample pretreatment method. The method comprises the steps of 1) mixing up a plant sample, an internal standard substance and a hydrophilic organic solvent, wherein the hydrophilic organic solvent is pre-cooled to be -20 to 4 DEG C; cooling the obtained mixture to be -80 to -10 DEG C, grinding, crushing and conducting the supersonic extraction in the ice-water bath; 2) then respectively adding a lipophilic organic solvent and water, uniformly mixing up, conducting the supersonic extraction in the ice-water bath, conducting the high-speed centrifugation at the temperature of 0 to 16 DEG C, obtaining the aqueous phase and evaporating; 3) adding an oximation reagent, and conducting the oximation reaction at the temperature of 30 to 45 DEG C; 4) finally adding a derivatization reagent and n-hexane, and conducting the derivatization reaction at the temperature of 60 to 80 DEG C. According to the technical scheme of the invention, based on the above pretreatment method, the primary metabolites of a plant sample can be fully extracted, so that the abundant metabolite spectrum data information can be obtained. Meanwhile, both the change of metabolites during the extraction process, and the pollution of liposoluble substances to a gas chromatographic column can be avoided as much as possible. Therefore, the better sample reproducibility is realized.
Owner:上海鹿明生物科技有限公司

Disease prediction method and system based on medical big data

The invention discloses a disease prediction method and system based on medical big data. The method comprises the following steps: importing mass spectrum data of mainstream mass spectrum instrumentmanufacturers, and completing the conversion from original mass spectrum data of the manufacturers to a general data format; realizing automatic labeling and qualitative analysis of endogenous compounds in the mass spectrum through a metabolite compound database according to the spectrum information of the endogenous metabolites of the individual human body and a compound search matching algorithm; wherein the loading is used for effectively managing huge and complex human body metabonomics samples and carrying out data mining and modeling, and the loaded data types mainly comprise targeted and non-targeted metabonomics mass spectrum original data and labeling results; performing standardized cleaning, compound alignment and qualitative and quantitative analysis on complex multi-sample data, and performing correction by adopting a multi-class algorithm; and adopting a machine learning model training set algorithm with different types of mass spectrum data processing characteristics tocomplete the whole process of training, publishing and maintaining the user disease prediction model.
Owner:质美(北京)生物科技有限公司

Method for identifying less than 25 pieces of pseudo-ginseng and less than 80 pieces of pseudo-ginseng based on non-targeted metabonomics

ActiveCN113419000AUnlock the Limits of Accurate Quantitative IdentificationHigh resolutionComponent separationMedicinal herbsNon targeted metabolomics
The invention provides a method for identifying 25 or less pseudo-ginseng and 80 or less pseudo-ginseng based on non-targeted metabonomics, and belongs to the field of analysis and detection of traditional Chinese medicinal materials, the method comprises the following steps: S1, extracting a pseudo-ginseng metabolite by using a methanol solution as a solvent to obtain a test sample; S2, carrying out non-targeted component determination on the pseudo-ginseng metabolite extracting solution by adopting a UHPLC LTQ Oribitrap MS (Ultra High Performance Liquid Chromatography LTQ Oribitrap Mass Spectrometry) combined technology to obtain original data; S3, performing preprocessing and multivariate statistical analysis on the original data in sequence; and S4, screening differential metabolites by taking the variable importance projection index as a screening index. According to the method, the differential metabolites of the pseudo-ginseng of different specifications are screened on the basis of integral analysis of the pseudo-ginseng, the UHPLC LTQ Oribitrap MS technology is combined with non-targeted metabonomics and principal component analysis, the method can be used for accurately distinguishing the pseudo-ginseng of different commodity specifications, and a theoretical basis is provided for specification standards of medicinal material commodities in the pseudo-ginseng market.
Owner:INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI +1

GC-MS-based sample pretreatment method for plant non-targeted metabolomics

The invention discloses a GC-MS-based plant non-targeted metabolomics sample pretreatment method. The method comprises the steps of 1) mixing up a plant sample, an internal standard substance and a hydrophilic organic solvent, wherein the hydrophilic organic solvent is pre-cooled to be -20 to 4 DEG C; cooling the obtained mixture to be -80 to -10 DEG C, grinding, crushing and conducting the supersonic extraction in the ice-water bath; 2) then respectively adding a lipophilic organic solvent and water, uniformly mixing up, conducting the supersonic extraction in the ice-water bath, conducting the high-speed centrifugation at the temperature of 0 to 16 DEG C, obtaining the aqueous phase and evaporating; 3) adding an oximation reagent, and conducting the oximation reaction at the temperature of 30 to 45 DEG C; 4) finally adding a derivatization reagent and n-hexane, and conducting the derivatization reaction at the temperature of 60 to 80 DEG C. According to the technical scheme of the invention, based on the above pretreatment method, the primary metabolites of a plant sample can be fully extracted, so that the abundant metabolite spectrum data information can be obtained. Meanwhile, both the change of metabolites during the extraction process, and the pollution of liposoluble substances to a gas chromatographic column can be avoided as much as possible. Therefore, the better sample reproducibility is realized.
Owner:上海鹿明生物科技有限公司

Hydroxyl metabolite derivatization method and non-targeted metabonomics efficient analysis method

The invention relates to a hydroxyl metabolite derivatization method and a non-targeted metabonomics efficient analysis method. The hydroxyl metabolite derivatization method comprises the steps that 1, hydroxyl metabolite extraction is conducted on a sample to be detected through a first solvent, then drying is conducted to remove the first solvent, and a dried sample is obtained; and 2, the dried sample is mixed with a second solvent to dissolve the dried sample, then 4-dimethylaminopyridine and dansyl chloride are added, the solution and the added substances are well mixed, and heating is performed for incubation; and after incubation is completed, sodium hydroxide is added, then heating is conducted for incubation, finally formic acid is added, and a derivatizated sample is obtained. According to the non-targeted metabonomics efficient analysis method, 12C labeling and 13C labeling are synchronously carried out by adopting the derivatization method, so that the metabolite detection sensitivity is improved, more metabolite can be detected at the same time, and the metabolite coverage rate is higher; and the detected metabolite is a peak pair, so that the influence caused by instrument drift and matrix is reduced, and the quantification is more accurate.
Owner:厦门市迈理奥科技有限公司

Metabonomics analysis method of multi-dimensional MXene nano material

The invention relates to the field of nano material preparation and metabonomics analysis, in particular to a metabonomics analysis method of a multi-dimensional MXene nano material. The metabonomics analysis method provided by the invention comprises the following steps: (1) carrying out DESI-MSI scanning on a biological sample to obtain DESI-MSI detection results of water-soluble metabolites and fat-soluble metabolites; the biological sample being collected from an animal model given with a multi-dimensional MXene nanomaterial; wherein the DESI-MSI detection conditions comprise that in a positive mode, the voltage is 5-6 kV; in the negative mode, the voltage being -4.5 to -5 kV; the spatial resolution being 50 to 80 [mu] m; the solvent spray being a 90-95% v / v methanol aqueous solution containing 0.1-0.5% v / v formic acid; and (2) carrying out space metabonomics analysis on the DESI-MSI detection result. In addition, the metabonomics analysis method disclosed by the invention can also comprise the step of carrying out non-targeted metabonomics detection and analysis on the cells co-cultured by the multi-dimensional MXene nano material. The method provides a basis for evaluating a multi-dimensional MXene nano material synthesis technology and biological response characteristic evaluation, and has a wide application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

A method for screening the material basis of anti-myocardial ischemia efficacy of Sini Decoction

The invention discloses a method for screening myocardial ischemia resisting pharmacodynamic material basis of yang exhaustion treating decoction. The method comprises the following steps: 1, determining myocardial ischemia resisting endogenous metabolin of the yang exhaustion treating decoction and measuring the peak area; 2, determining in-vivo migration constituents in the yang exhaustion treating decoction and measuring the peak area; 3, performing correlation analysis on the peak area of the myocardial ischemia resisting endogenous metabolin of the yang exhaustion treating decoction and the peak area of the in-vivo migration constituents in the yang exhaustion treating decoction and screening out myocardial ischemia resisting pharmacodynamic material basis of the yang exhaustion treating decoction. The method disclosed by the invention is based on isoproterenol-induced rat myocardial ischemia model; an ultrahigh performance liquid chromatography-quadrupole rod-flight time mass spectrum non-targeted metabonomic technology and a targeted metabonomic technology based on an ultrahigh performance liquid chromatography-triple quadrupole rod mass spectrum are utilized to screen out 12 kinds of myocardial ischemia resisting pharmacodynamic material basis of the yang exhaustion treating decoction; thus, accuracy of the myocardial ischemia resisting pharmacodynamic material basis ofthe yang exhaustion treating decoction is improved, a screening period is shortened, and screening consumption cost is reduced.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products